From the +Departamento de Metabolismo, Nutricion y Hormonas, Fundacion Jimenez Diaz, Madrid-3, and the 1)Instituto de Enzimologia y Patologia Molecular del CSIC, Facultad de Medicina de la UAM, Spain Glucagon produces a time-and dose-dependent activation of phospholipid methyltransferase activity in isolated rat hepatocytes. Half-maximal effect is caused by a dose of glucagon of 1 X 10"' M. This activation is due to an increase of the V,, value of the enzyme, without affecting the K,,, value for S-adenosylmethionine. Exogenous cyclic AMP added to isolated rat hepatocytes mimics the effect of glucagon, and the activation of phospholipid methyltransferase by a nonsaturating concentration of glucagon is spontaneously reversible within 40 min of incubation.
activation of this enzyme from isolated rat hepatocytes treated with glucagon. T h i s activation is due to an increase in the Vmax value of the enzyme and is mimicked by CAMP.
EXPERIMENTAL PROCEDURES
lated from normally fed Wistar rats (250 to 300 g) as described by Isolation and Incubation of Hepatocytes-Hepatocytes were isoCasta60 et al. (14) . Isolated hepatocytes were incubated as follows: 2 ml of cell suspension (30 to 50 mg wet weight/ml of suspension) were shaken (150 strokes/min) in stoppered 20-1111 vials at 37°C in the presence of 10 mM glucose. The gas phase was 95% 0 2 and 5% COa. After 30 min of preincubation, glucagon, CAMP, or saline (0.9% NaCl solution) were added. For the phospholipid methyltransferase assay, the suspension of hepatocytes at the time indicated was poured into precooled centrifuge tubes and immediately centrifuged at lo00 X g for 20 s. The supernatant was discarded and the pellet was immediately frozen in a dry ice-acetone bath.
Measurement of Enzyme Actioity-For the determination of phosphohpid methyltransferase activity, 0.2 ml of homogenization buffer (50 mM 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid (Hepes), 100 m~ KF, 15 mM ethylene glycol bis(P-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA), pH 7.4) were added to the frozen aliquots then vigorously shaken in a mixer until the sample was completely thawed. Further homogenization was not necessary and did not increase phospholipid methyltransferase activity. The resultant homogenate was directly used for assay in a reaction mixture that contained, in a final volume of 0.550 ml, 10 mM 4-(2-hydroxyethyl)-lpiperazineethanesulfonic acid (Hepes), pH 7.3, 4 m~ dithiothreitol, 6% sucrose, 5 m~ MgCL, 100 p~ S-adenosylmethionine, 2 pCi of Sadenosyl-~-[rnethyl-:'H]methionine (Amersham, 15 Ci/mmol) or 0.5 pCi of S-adeno~yl-L-[methyl-'~C]methionine (Amersham, 58 mCi/ mmol) and usually 50 p1 of homogenate. The reaction was initiated by the addition of a mixture of the labeled and unlabeled S-adenosylmethionine and terminated by pipetting 100 pl of assay mixture into 2 ml of chloroform/methanol/2 N HCI (6:3:1. v/v) for lipid extraction (10). The chloroform phase was washed with 1 ml of 0.5 M KC1 in 50% methanol. After washing, 0.7 ml of the chloroform phase was pipetted into a counting vial, dried at room temperature, dissolved in 5 ml of Triton X-lOO/toluol-based scintillator, and counted. The reaction was linear with time of incubation, up to 60 min and with the amount of homogenate added (from 10 to 200 gl), for homogenates from both control and glucagon-treated hepatocytes.
The known inhibitor of transmethylation, S-adenosyl-L-homocysteine, added to the reaction mixture at a final concentration of 1 mM, produces a 90% inhibition of the enzymatic reaction.
To separate and quantitate the various methylated phospholipids, the chloroform phase was dried at room temperature under a stream of N2 gas and the residue was dissolved in 0.5 ml of chloroform. A sample, usually 0.2 ml, was then applied to a silica gel plate (Silica Gel plates 60, Merck) and developed by ascendant chromatography with propionic acid/n-propyl alcohol/chloroform/water (2:2:1:1, v/v) for phospholipid separation (IO). After the front migrated 14 cm, the silica gel was scraped into 5-mm bands. Each band was then eluted with 0.5 ml of the solvent used for chromatography and, after 6-h incubation at room temperature, 0.4 ml was pipetted into a counting vial, dried at 7OoC, dissolved in 5 ml of scintillator, and counted. Biochemicals were from Sigma or Boehringer. Other reagents were of analytical reagent grade.
RESULTS AND DISCUSSION
Treatment of isolated rat hepatocytes with glucagon M) produces a time-dependent activation of phospholipid methyltransferase activity (Fig. 1) . Maximal activation is about 2-fold and is attained 5 min after the addition of the hormone.
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Liver Phospholipid Methyltransferase Activation
by Glucagon CAMP (0.1 mM) added to isolated rat hepatocytes can partidy mimic the effect of glucagon ( Table I) . The concentration of cAMP that produces the same activation as glucagon on phospholipid methyltransferase activity is markedly reduced when the incubation of hepatocytes with cAMP is made in the presence of phosphodiesterase inhibitor (50 ~Z M MIX') ( Table I) . NaF, a known direct activator of adenylate cyclase that has been shown to increase intracellular cAMP concentrations in isolated rat hepatocytes (16), added to the incubation of hepatocytes in the presence of phosphodiesterase inhibitor (50 PM MIX), also activates phospholipid methyltransferase activity (Table I) .
Glucagon treatment of hepatocytes changes the kinetic properties of phospholipid methyltransferase, increasing the V,,, value of the enzyme, without affecting the K,,, value for S-adenosylmethionine (Fig. 2) . Addition to the reaction mixture of dipalmitoyl phosphatidylethanqlamine (1 mg) does not change the observed enzyme activity, for homogenates from either control or glucagon-treated hepatocytes.
The pattern of labeled phospholipids isolated from the reaction mixture that contained homogenates from control or glucagon-treated hepatocytes is shown in Fig. 3 . Corresponding to the increase of the V,,, value of the enzyme caused by glucagon, there is an increase in the incorporation of labeled methyl groups into phosphatidyl-N-methylethanolamine, phosphatidyl-N,N-dimethylethanolamine, and phosphatidylcholine.
The dose-dependent activation of phospholipid methyltransferase activity by glucagon is shown in Fig. 4 . Halfmaximal activation is approximately observed at a dose of glucagon of 1 X 10"" M, which is in the range of the physiological concentrations of the hormone (17) .
As shown in Fig. 5 , the activation of phospholipid methyltransferase by a nonsaturating dose of glucagon (3 X 10"" M) is spontaneously reversible within 40 min of incubation. This result indicates that a proteolytic mechanism for the short term effect of glucagon on the enzyme activity can be discarded.
The activation of phospholipid methyltransferase activity by glucagon seems to be a CAMP-dependent process because: (a) cAMP and NaF, a known activator of adenylate cyclase, added to isolated rat hepatocytes also activate the enzyme, ( b ) the dose of glucagon that produces half-maximal activation ' The abbreviation used is: MIX, I-methyl-3-isobutylxanthine. of the enzyme is similar to that reported for other known CAMP-dependent actions of glucagon, i.e. inactivation of phosphofructokinase and pyruvate kinase L (14) . As for other effects of glucagon in liver that are mediated by CAMP, it can be suggested that a CAMP-dependent phosphorylation or dephosphorylation of the enzyme could be involved in the mechanism of activation of phospholipid methyltransferase by glucagon. The possible physiological role of the activation of phospholipid methyltransferase by glucagon in isolated rat hepatocytes remains to be established. As phospholipid methyla- tion has been shown to affect membrane structure (18), it be suggested that the increase of phospholipid methyltransferase activity by glucagon could probably affect processes in which membranes, especially of the endoplasmic reticulum, are involved, including membrane transport and the activity of membrane-bound enzymes.
